Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Get real-time Poniard Pharmaceuticals (PARD) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to inform your investment decisions.
Find the latest Poniard Pharmaceuticals, Inc. (PARD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Poniard Pharmaceuticals, Inc. (PARD) profitability grade and underlying metrics. Quant Ratings. Charts: gross margin, EBIT, Net Income, EBITDA, ROE, ROA, etc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results